Austin-area robotic architecture firm ICON and pharmaceutical company Cassava Sciences combined to layoff over 120 workers ...

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) has been given an average rating of “Moderate Buy” by the thirteen ratings firms that are presently covering the stock, Marketbeat.com ...

Analyst Jonathan Wolleben of JMP Securities reiterated a Buy rating on Madrigal Pharmaceuticals (MDGL – Research Report), with a price target ...

Bank of America Securities analyst Jason Zemansky maintained a Sell rating on Madrigal Pharmaceuticals (MDGL – Research Report) today and set a ...

Ascentage Pharma (6855.HK) is a global, integrated biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily in ...

Ascentage Pharma (6855.HK) is a global, integrated biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily in ...

Next up in the roster of companies trying to bring a NASH drug top market is Madrigal Pharma, with its resmetirom candidate, due to be filed for approval shortly. Viking Therapeutics (VK2809 ...

Latest on INO: Exclusive BAC Article: Inovio Pharmaceuticals; BLA Filing INO-3107 For RRP 2nd Half Of 2024, GBM Program Update INO-5401 1st Half Of 2024 And Catalysts ...

Significant stake increases in Madrigal Pharma, now the largest position at ~28% of the portfolio, and Tellurian Inc. Key holdings such as Perpetua Resources, BrightSphere Investment Group ...